Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Fuji
US Army
AstraZeneca
Cipla
Colorcon
Deloitte
Moodys
Express Scripts

Generated: January 21, 2018

DrugPatentWatch Database Preview

Ramipril - Generic Drug Details

« Back to Dashboard

What are the generic sources for ramipril and what is the scope of ramipril patent protection?

Ramipril
is the generic ingredient in two branded drugs marketed by King Pharms Llc, Accord Hlthcare, Actavis Elizabeth, Apotex, Aurobindo Pharma Ltd, Cipla, Dr Reddys Labs Ltd, Invagen Pharms, Lupin, Ranbaxy Labs Ltd, Sandoz, Teva Pharms, Watson Labs, West-ward Pharms Int, Zydus Pharms Usa, King Pfizer, Apotex Inc, Mylan Pharms Inc, and Zydus Pharms Usa Inc, and is included in nineteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Ramipril has forty-six patent family members in thirty-one countries.

There are nineteen drug master file entries for ramipril. Thirty-six suppliers are listed for this compound.
Pharmacology for ramipril
Medical Subject Heading (MeSH) Categories for ramipril

US Patents and Regulatory Information for ramipril

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd RAMIPRIL ramipril CAPSULE;ORAL 091604-003 Jun 8, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Ltd RAMIPRIL ramipril CAPSULE;ORAL 078191-004 Jun 18, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth RAMIPRIL ramipril CAPSULE;ORAL 077513-004 Jun 18, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cipla RAMIPRIL ramipril CAPSULE;ORAL 077004-002 Aug 7, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int RAMIPRIL ramipril CAPSULE;ORAL 077900-004 Jun 18, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Zydus Pharms Usa RAMIPRIL ramipril CAPSULE;ORAL 078832-002 Sep 2, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Zydus Pharms Usa Inc RAMIPRIL ramipril TABLET;ORAL 090697-002 Sep 24, 2009 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth RAMIPRIL ramipril CAPSULE;ORAL 077513-001 Jun 18, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Invagen Pharms RAMIPRIL ramipril CAPSULE;ORAL 078745-001 Jun 18, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc RAMIPRIL ramipril TABLET;ORAL 090650-002 Jun 30, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ramipril

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc ALTACE ramipril CAPSULE;ORAL 019901-002 Jan 28, 1991 ➤ Subscribe ➤ Subscribe
King Pharms Llc ALTACE ramipril CAPSULE;ORAL 019901-004 Jan 28, 1991 ➤ Subscribe ➤ Subscribe
King Pfizer ALTACE ramipril TABLET;ORAL 022021-004 Feb 27, 2007 ➤ Subscribe ➤ Subscribe
King Pharms Llc ALTACE ramipril CAPSULE;ORAL 019901-001 Jan 28, 1991 ➤ Subscribe ➤ Subscribe
King Pfizer ALTACE ramipril TABLET;ORAL 022021-004 Feb 27, 2007 ➤ Subscribe ➤ Subscribe
King Pharms Llc ALTACE ramipril CAPSULE;ORAL 019901-003 Jan 28, 1991 ➤ Subscribe ➤ Subscribe
King Pfizer ALTACE ramipril TABLET;ORAL 022021-002 Feb 27, 2007 ➤ Subscribe ➤ Subscribe
King Pfizer ALTACE ramipril TABLET;ORAL 022021-001 Feb 27, 2007 ➤ Subscribe ➤ Subscribe
King Pharms Llc ALTACE ramipril CAPSULE;ORAL 019901-004 Jan 28, 1991 ➤ Subscribe ➤ Subscribe
King Pfizer ALTACE ramipril TABLET;ORAL 022021-001 Feb 27, 2007 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for ramipril

Supplementary Protection Certificates for ramipril

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB98/047 United Kingdom ➤ Subscribe PRODUCT NAME: COMBINATIONS OF RAMIPRIL, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, AND FELODIPINE, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF.; REGISTERED: SE 13596 19970919; SE 13597 19970919; UK 00017/0402 19980825; UK 00017/0403 19980825
C0001 Belgium ➤ Subscribe PRODUCT NAME: FELODIPINUM + RAMIPRILUM; NATL. REGISTRATION NO/DATE: 354 IS 373 F 3 19981103; FIRST REGISTRATION: SE 13597 19970919
80030 Netherlands ➤ Subscribe PRODUCT NAME: FELODIPINE, DESGEWENST IN DE VORM VAN FYSIOLOGISCH AANVAARDBAAR ZOUT, EN (2S, 3AS, 6AS)-1-[(S)-N-[(S)-1-CARBOXY-3-FENYLPROPYL]A LANYL]OCTAHYDROCYCLOPENTA[B]-PYRROOL-2-CARBONZUUR (RAMIPRILAAT) , DESGEWENST IN DE VORM VAN EEN .....ZIE VERDER IN HET DOSSIER; NAT. REGISTRATION NO/ DATE: RVG 22449, RVG 22450 19980618; FIRST REGISTRATION: SE 13596, 13597 19970919
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cerilliant
Daiichi Sankyo
Baxter
Dow
Fuji
Medtronic
Cantor Fitzgerald
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot